HCM II Acquisition Corp. (NASDAQ:HOND - Get Free Report) shares gapped up before the market opened on Monday . The stock had previously closed at $18.86, but opened at $21.69. HCM II Acquisition shares last traded at $21.21, with a volume of 1,141,468 shares traded.
Wall Street Analysts Forecast Growth
Separately, Weiss Ratings reissued a "sell (d-)" rating on shares of HCM II Acquisition in a report on Wednesday, October 8th. One equities research analyst has rated the stock with a Sell rating, According to MarketBeat.com, the company has an average rating of "Sell".
Get Our Latest Report on HCM II Acquisition
HCM II Acquisition Trading Up 9.6%
The stock has a fifty day moving average of $13.17 and a two-hundred day moving average of $11.81.
Institutional Trading of HCM II Acquisition
Institutional investors have recently bought and sold shares of the company. North Capital Inc. purchased a new stake in HCM II Acquisition during the second quarter worth $67,000. Patriot Financial Group Insurance Agency LLC purchased a new stake in HCM II Acquisition during the second quarter worth $209,000. Mizuho Securities USA LLC purchased a new stake in HCM II Acquisition during the first quarter worth $271,000. FNY Investment Advisers LLC boosted its position in HCM II Acquisition by 41,400.0% during the second quarter. FNY Investment Advisers LLC now owns 41,500 shares of the company's stock worth $460,000 after purchasing an additional 41,400 shares in the last quarter. Finally, JPMorgan Chase & Co. purchased a new stake in HCM II Acquisition during the second quarter worth $552,000.
About HCM II Acquisition
(
Get Free Report)
HCM II Acquisition Corp. operates as a blank check company. It was formed for the purpose of entering into a merger, amalgamation, share exchange, asset acquisition, share purchase, reorganization or similar business combination with one or more businesses. The company was founded on April 4, 2024 and is headquartered in Stamford, CT.
Recommended Stories
This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest and most accurate reporting. This story was reviewed by MarketBeat's editorial team prior to publication. Please send any questions or comments about this story to contact@marketbeat.com.
Before you consider HCM II Acquisition, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and HCM II Acquisition wasn't on the list.
While HCM II Acquisition currently has a Sell rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
Discover the next wave of investment opportunities with our report, 7 Stocks That Will Be Magnificent in 2025. Explore companies poised to replicate the growth, innovation, and value creation of the tech giants dominating today's markets.
Get This Free Report
Like this article? Share it with a colleague.
Link copied to clipboard.